Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // May 25th, 2010 // 6:48 am
Hello, again. A shiny day here on the Pharmalot corporate campus, where we expect a busy day. How about you? Much to do? We look forward to shortening our to-do list. To get started, we are quaffing the usual cup of stimulation and rummaging through the news of the world. Hope your day goes well and drop us a line if you hear anything interesting….
Astellas Hires 300 Reps In China (Bloomberg News)
FDA Extends Review Of Novartis MS Drug (PharmaTimes)
Abbott Labs Plans To Sell $3B In Debt (BioValley)
Genzyme Agrees To $175M Consent Decree (Bloomberg News)
Execs Worry About FDA’s BadAd Program (Advertising Age)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Abbott Laboratories, Astellas, Bad Ad, China, FDA, Genzyme, Novartis